John Glenn - 22 Mar 2022 Form 4 Insider Report for EKSO BIONICS HOLDINGS, INC. (EKSO)

Reporting relationship: Chief Financial Officer
Issuer ticker: EKSO
Reported as of: 22 Mar 2022
Net transaction value: -$9,762
SEC form: 4
Accepted by SEC: 28 Mar 2022, 16:52:54 UTC
Prior SEC filing: 22 Feb 2022
Next SEC filing: 08 Jul 2022
Source filing: View source filing
Reporting owner signature: /s/ Jerome Wong, as Attorney-in-Fact

Key filing fact

John Glenn filed Form 4 for EKSO BIONICS HOLDINGS, INC. (EKSO) on 28 Mar 2022.

Key facts

This page summarizes John Glenn's Form 4 filing for EKSO BIONICS HOLDINGS, INC. (EKSO).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 28 Mar 2022, 16:52.

Change

Previous filing in this sequence was filed on 22 Feb 2022.
Current net transaction value: -$9,762.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EKSO transaction

Common Stock

Sale

Transaction value: $9,762
Shares: -3,462
Change %: -9%
Price: $2.82
Shares after: 35,130
Date: 22 Mar 2022
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents shares sold by the Reporting Person on March 22, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the first installment of restricted stock awards reported by the Reporting Person in Form 4s filed with the Commission on February 22, 2022 and March 5, 2021.

Footnote F2

The sale price represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $2.88 to $2.81, inclusive. The Company can provide the full information regarding the number of shares sold at each separate price upon further request.